Lesions with Indication for EUS-FNA
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age =or >20 (2) Requirement of EUS-FNA of a solid lesion (3) Use of the 25-gauge Franseen needle (4) Providing written informed consent
Exclusion criteria
Exclusion criteria: (1) Cystic lesion (2) PT-INR =or >1.5 (3) Platelate count < 50000/m3 (4) ASA =or >3 (5) ECOG-PS=4 (6) Pregnancy (7) Unsuitable for inclusion at the discretion of the physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The tissue acquisition rate in the initial puncture | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Quality of a tissue sample (2) Diagnostic accuracy Diagnostic accuracy, sensitivity, specificity, PPV, NPV in (3) pathological and (4) cytological malignancy or benignancy (5) Success rate of puncture (6) Adverse event rate in EUS-FNA | — |
Countries
Japan
Contacts
Hokkaido University Faculty of Medicine and Graduate School of Medicine Department of Gastroenterology and Hepatology